JLABS | The Race to Market: Building an Efficient Discovery Engine

June 8, 2017

Share :

Time: 8:30AM - 11:30AM
Location: Lobby
RSVP LabCentral residents contact Luke for the free code

Are you confident in the integrity of your data? Every day, hundreds of scientists are generating, analyzing and managing data that form the basis to discover and develop new drugs that patients are waiting for. Laboratory data forms the building blocks of the scientific work, and its quality is critical to crucial business decisions and long term success. Johnson & Johnson Innovation, JLABS (JLABS) and Janssen R&D invite you to take an in-depth look into potential quality risks in research and explore measures to improve data quality in the drug discovery processes.

From emerging startup to big pharma - your company’s reputation, intellectual property protection and decision making depends on high quality data.

Presentation Topics:

  • Journey to bringing a drug to market
  • Dilemmas in discovery – a workshop
  • Reproducibility in research
  • A quality approach within Janssen R&D


  • David Malwitz | Program Manager, Bioresearch Quality & Compliance , Janssen R&D
  • Michael Elliott | VP, Immunology Scientific Innovation, Johnson & Johnson Innovation


  • 8:30 AM | Registration, Breakfast & Networking
  • 9:00 AM | Journey to bringing a drug to market
    • Drug discovery process
    • Internal and external stakeholders
    • Opportunities and challenges
  • 9:25 AM | Dilemmas in discovery – a workshop
    • An interactive session focusing on potential data handling dilemmas and their associated risks
  • 10:40 AM | Discovery data integrity – a quality approach for Janssen R&D
    • Sponsorship and support
    • Training approach
    • Risk-based monitoring
    • Phase appropriate solutions
  • 11:00 AM | Discussion and Q&A
  • 11:30 AM | Program Close